The Bank of Japan is likely to hold its key interest rate through June, showed a Reuters survey of economists, with a ...

Belo, a member of PRWeek’s 2024 Health Influencer list, joined Takeda in 2021 as VP and global head of external communications. The company promoted him to SVP and head of global corporate brand and ...

Keros Therapeutics halted phase 2 of TROPOS, but KER-065 shows promise in DMD and financial stability ensures growth ...

The biotech has launched a strategic review to consider options, including a possible sale, following shareholder pressure.

Ironwood Pharmaceuticals (IRWD) is undergoing a challenging transition with LINZESS but has promising growth potential with ...

In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited ... to Insider Monkey’s database of 900 as of Q3 2024. Why are we interested in the stocks that ...

We came across a bullish thesis on Harmony Biosciences Holdings, Inc. (HRMY) on Value Investing Subreddit Page by Long-Access-2143. In this article, we will summarize the bulls’ thesis on HRMY.

Past collaborations included Takeda, Sanofi Bristol Myers Squibb ... comfortable financial position for an early-stage drug discovery company, with $625M in Q3 2022, for a net cash burn of just $15M.

These programs are developed in partnership with Pfizer, Novartis, Biogen, and Takeda. The company has invested heavily ... In the last quarter (Q3 2022), the company had $62M in current assets. Net ...

The Keychron Q3 HE is a great compact mechanical keyboard, one that offers lots of customization thanks to its Hall Effect switches. It's 2025 and it's raining keyboards, be they big, small ...

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up to five rare disease programmes. The alliance ...

Takeda has announced a $100 million collaboration with Abingworth to work with GammaDelta Therapeutics, a UK biotech which is pioneering a novel type of T cell therapy. The Japanese pharma company ...